Latest filing published 02 Mar 2023 for Outset Medical, Inc., €23k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Martin Vazquez, listed as senior executive, appears in our data through filings on Outset Medical, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 17 September 2020 to 1 March 2023, the count stands at 102 filings.
Both buying and selling appear: 1 purchase worth €23k, against 52 sales worth €8.4M. The net balance comes to €8.4M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants and 44 option exercises. So far in 2023, the count stands at no purchases and 9 sales.
The record was last updated on 2 March 2023 with an option exercise (€23k) in Outset Medical, Inc. The last insider purchase was made public on 17 September 2020, 2,228 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 87 declarations